UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report)'s share price traded down 1.1% on Wednesday . The company traded as low as $358.00 and last traded at $361.29. 7,327,250 shares were traded during trading, a decline of 41% from the average session volume of 12,485,646 shares. The stock had previously closed at $365.37.
Analyst Ratings Changes
A number of analysts have recently weighed in on the company. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Wells Fargo & Company upped their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 7th. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. JPMorgan Chase & Co. boosted their target price on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an "overweight" rating in a research note on Thursday, October 9th. Finally, Morgan Stanley boosted their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research note on Friday, September 12th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of "Hold" and a consensus price target of $385.13.
Check Out Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Stock Down 1.1%
The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market cap of $327.21 billion, a price-to-earnings ratio of 15.65, a P/E/G ratio of 2.36 and a beta of 0.47. The firm's 50 day simple moving average is $333.70 and its 200-day simple moving average is $341.28.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the company earned $6.80 EPS. The business's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group's dividend payout ratio is currently 38.30%.
Institutional Investors Weigh In On UnitedHealth Group
Several hedge funds have recently made changes to their positions in the business. Nabity Jensen Investment Management Inc boosted its stake in shares of UnitedHealth Group by 0.9% during the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate's stock worth $1,446,000 after buying an additional 24 shares during the period. Atlantic Edge Private Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate's stock valued at $160,000 after buying an additional 25 shares in the last quarter. HHM Wealth Advisors LLC increased its holdings in UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate's stock valued at $1,544,000 after buying an additional 26 shares in the last quarter. Brogan Financial Inc. increased its holdings in UnitedHealth Group by 3.4% in the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate's stock valued at $429,000 after buying an additional 27 shares in the last quarter. Finally, West Wealth Group LLC increased its holdings in UnitedHealth Group by 3.2% in the first quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate's stock valued at $462,000 after buying an additional 27 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
About UnitedHealth Group
(
Get Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
